Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.

@article{Chhatrala2015EvolutionOS,
  title={Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.},
  author={Ravi Chhatrala and M Bilal Siddiqui and Richard Todd Stravitz and Carolyn J Driscoll and Arun J Sanyal and Carol C Sargeant and Velimir A.C. Luketic and Amritansh Sharma and Richard Keith Sterling and Scott C Matherly and Puneet Puri and Mohammad Shadab Siddiqui},
  journal={Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society},
  year={2015},
  volume={21 5},
  pages={623-30}
}
Although cardiovascular disease (CVD) is the leading cause of long-term mortality in liver transplant recipients (LTRs), the role of recently identified biomarkers of CVD risk in liver transplantation is unknown. We aimed to evaluate an extensive CVD risk profile in LTRs. Markers of CVD risk in 65 LTRs with no known history of diabetes mellitus (DM), dyslipidemia, or ischemic heart disease were compared to age-, sex-, and body mass index (BMI)-matched controls with no chronic medical disease… CONTINUE READING